Literature DB >> 32451579

The baby lung and the COVID-19 era.

Luciano Gattinoni1, Konrad Meissner2, John J Marini3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32451579      PMCID: PMC7246291          DOI: 10.1007/s00134-020-06103-5

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
The concept of the baby lung was born in 1987 [1] when quantitative CT scan analysis demonstrated that, in severe ARDS, the amount of the ventilatable lung tissue of an adult was similar to that of a 6-year-old healthy child. We called it a “baby lung.” Three features seemed apparent: (1) The baby lung was anatomically located in the non-dependent lung regions (parasternal, when supine), while the radiological densities were primarily located in the dependent regions (paravertebral); (2) the respiratory system compliance was a useful tool with which to estimate the baby lung size [1]. Indeed, compliance was not an inverse function of the amount of non-aerated tissue, but instead correlated strongly with the amount of well-aerated lung. In other words, measured compliance characterizes only those lung units that receive the gas volume. This finding changed a prevailing concept of ARDS important to its management: The lung was not stiff, as commonly believed at that time, but small; (3) the specific compliance (i.e., respiratory system compliance measured in the ventilating circuit normalized to the size of the baby lung) was similar for healthy individuals and ARDS patients. That fact does not necessarily mean that the baby lung is healthy, but does indicate that its mechanical characteristics are preserved, exclusive of the possible presence of fibrosis or deficit of surfactant. The anatomical location of the baby lung led us to introduce the prone position as a treatment for ARDS [2]. Indeed, we thought that the anatomically situated parasternal baby lung should be better perfused in the prone position, with resulting improvement in oxygenation and possibly a decrease in PaCO2. Actually, an increase in oxygenation was observed in the majority of patients, with PaO2 increasing even more than 100 mmHg for the same FiO2. However, almost one year later, we also took a CT scan in the prone position, and to our surprise, we found that the anatomically envisioned baby lung disappeared in the parasternal regions, while a new baby lung appeared in the dorsal zone [3]. This finding convincingly negated the concept of the anatomical baby lung and replaced it with the concept of the functional baby lung. Understanding the mechanism behind this positional switch implied the need to perform and compare regional analyses of CT in both supine and prone positions. Doing so led to the model of the “sponge lung” [4]. Indeed, the densities in the dependent lung regions, whether in supine or prone positions, were primarily due to superimposed hydrostatic pressures that compress the lung along the vertical gravitational axis. More importantly, it appeared evident that the densities were not due to the movement of edema but instead due to squeezing gas from the alveoli by compressive forces. This led also to a revised hypothesis for the mechanism of PEEP’s benefit, which now would act as a counterforce against superimposed pressure, thereby preventing the expulsion of alveolar gas and atelectasis. This model, actually without significant changes, held reasonably true until the COVID-19 era [5]. Several COVID patients at hospital presentation met the broad ARDS definition criteria. Indeed, the hypoxemia qualifies, on the basis of PaO2/FiO2, and bilateral infiltrates on chest X-ray are present. However, even though many authors continue to characterize this presentation as “ARDS” (which is a syndrome) and proceed accordingly, it must be recognized that, in many cases, we deal with an atypical ARDS [6]. Indeed, at the beginning this atypical syndrome does not show a baby lung, but as measured by the quantitative CT scan an “adult lung,” with normal mechanics and normal specific compliance [7]. It would be interesting to know, however, if and how the adult lung of early or mild COVID-19 pneumonia transitions to a baby lung. Is this due only to disease progression or also to inappropriate treatment which, in the absence of interventions, forces the adult lung to shrink progressively and deteriorate through a sort of “VILI vortex” [8] of concentrating injurious mechanical power [9]? After becoming infected, only a minority of COVID patients develop bilateral pneumonia and hypoxemia [10]. The radiological lesions present initially as “ground glass” infiltrates located primarily near the visceral pleura. This location is similar to the one we found in experimental animals when VILI is produced with high tidal volume [11]. In these patients, the hypoxemia is primarily due to the VA/Q maldistribution caused by the loss of the lung perfusion regulation. Respiratory drive is highly activated because of hypoxemia, infection, and possibly direct presence of virus in the central nervous system. High tidal volume follows (increased strain) in association with higher transpulmonary pressure (stress). If this increase in stress and strain remains without correction, patient self-inflicted lung injury develops, causing overt lung edema [12]. Dependent regions of the lung then tend to collapse due to the increased hydrostatic superimposed pressure [13], and the lung transitions from the adult size to the baby lung size, with a parallel decrease in respiratory system compliance. If the conditions leading to increased stress and strain remain unchecked, the VILI vortex develops. Indeed, for any increase in edema and reduction in the lung size, stress and strain are more concentrated in a smaller lung and promote a vicious cycle. It is therefore mandatory to interrupt this sequence of events which cause the baby lung to shrink and become more vulnerable. For many authors, the concept of VILI does not include the vascular side of the alveolus which is, in our opinion, of similar importance as the gas side, particularly in COVID. Indeed, the forces of mechanical power (a function of strain, stress, and respiratory rate) are primarily applied to the extracellular matrix to which both the epithelial and endothelial cells are anchored. The strain of these two cell populations contributes through a cytokine release to a further recruitment of inflammatory cells. Although the lung mechanics of the baby lung are not dramatically changed, the reaction to and tolerance of repeated cycles of high stress and strain is profoundly altered by the inflammatory reaction. This effect has been shown in CT-PET studies in which the inflammation was often recognized in the well-aerated tissue compartment [14]. It is beyond the purpose of this paper to discuss the therapy of COVID-19. At its core, however, is the prevention/interruption/reduction of the VILI vortex, keeping well in mind that PEEP modifies both stress and strain and contributes to the applied mechanical power [15]. In summary (Fig. 1), the baby lung concept evolved from a static representation (“anatomic entity located in the non-dependent lung”) to a static functional model (“sponge lung”) to dynamic entity subject over time to the VILI vortex if not maintained and preserved.
Fig. 1

Evolving concept of the “baby lung” of ARDS. Initial interpretation of the supine CT images suggested a fixed anatomical location (left panel). Subsequently, the shifting of the aerated compartment by prone repositioning demonstrated its lack of structurally fixed location, functional nature, and responsiveness to changes in transpulmonary pressure (middle panel). The vulnerability of aerated lung units to progressively concentrating power that injures and promotes dropout of lung units from the functional compartment over time is implicit in the current “dynamic” model of the shrinking baby lung (right panel)

Evolving concept of the “baby lung” of ARDS. Initial interpretation of the supine CT images suggested a fixed anatomical location (left panel). Subsequently, the shifting of the aerated compartment by prone repositioning demonstrated its lack of structurally fixed location, functional nature, and responsiveness to changes in transpulmonary pressure (middle panel). The vulnerability of aerated lung units to progressively concentrating power that injures and promotes dropout of lung units from the functional compartment over time is implicit in the current “dynamic” model of the shrinking baby lung (right panel)
  14 in total

1.  Lung inhomogeneities and time course of ventilator-induced mechanical injuries.

Authors:  Massimo Cressoni; Chiara Chiurazzi; Miriam Gotti; Martina Amini; Matteo Brioni; Ilaria Algieri; Antonio Cammaroto; Cristina Rovati; Dario Massari; Caterina Bacile di Castiglione; Klodiana Nikolla; Claudia Montaruli; Marco Lazzerini; Daniele Dondossola; Angelo Colombo; Stefano Gatti; Vincenza Valerio; Nicoletta Gagliano; Eleonora Carlesso; Luciano Gattinoni
Journal:  Anesthesiology       Date:  2015-09       Impact factor: 7.892

2.  Ventilation-induced lung injury exists in spontaneously breathing patients with acute respiratory failure: Yes.

Authors:  Laurent Brochard
Journal:  Intensive Care Med       Date:  2017-01-10       Impact factor: 17.440

3.  The ARDS lung. New insights from computed tomography.

Authors:  R C Bone
Journal:  JAMA       Date:  1993-04-28       Impact factor: 56.272

4.  Vertical gradient of regional lung inflation in adult respiratory distress syndrome.

Authors:  P Pelosi; L D'Andrea; G Vitale; A Pesenti; L Gattinoni
Journal:  Am J Respir Crit Care Med       Date:  1994-01       Impact factor: 21.405

5.  Ventilator-related causes of lung injury: the mechanical power.

Authors:  L Gattinoni; T Tonetti; M Cressoni; P Cadringher; P Herrmann; O Moerer; A Protti; M Gotti; C Chiurazzi; E Carlesso; D Chiumello; M Quintel
Journal:  Intensive Care Med       Date:  2016-09-12       Impact factor: 17.440

6.  Mechanical power of ventilation is associated with mortality in critically ill patients: an analysis of patients in two observational cohorts.

Authors:  Ary Serpa Neto; Rodrigo Octavio Deliberato; Alistair E W Johnson; Lieuwe D Bos; Pedro Amorim; Silvio Moreto Pereira; Denise Carnieli Cazati; Ricardo L Cordioli; Thiago Domingos Correa; Tom J Pollard; Guilherme P P Schettino; Karina T Timenetsky; Leo A Celi; Paolo Pelosi; Marcelo Gama de Abreu; Marcus J Schultz
Journal:  Intensive Care Med       Date:  2018-10-05       Impact factor: 17.440

7.  COVID-19: a novel coronavirus and a novel challenge for critical care.

Authors:  Yaseen M Arabi; Srinivas Murthy; Steve Webb
Journal:  Intensive Care Med       Date:  2020-03-03       Impact factor: 17.440

8.  COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome.

Authors:  Luciano Gattinoni; Silvia Coppola; Massimo Cressoni; Mattia Busana; Sandra Rossi; Davide Chiumello
Journal:  Am J Respir Crit Care Med       Date:  2020-05-15       Impact factor: 21.405

9.  COVID-19 pneumonia: different respiratory treatments for different phenotypes?

Authors:  Luciano Gattinoni; Davide Chiumello; Pietro Caironi; Mattia Busana; Federica Romitti; Luca Brazzi; Luigi Camporota
Journal:  Intensive Care Med       Date:  2020-04-14       Impact factor: 17.440

10.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

View more
  18 in total

1.  In Silico Modeling of Coronavirus Disease 2019 Acute Respiratory Distress Syndrome: Pathophysiologic Insights and Potential Management Implications.

Authors:  Anup Das; Sina Saffaran; Marc Chikhani; Timothy E Scott; Marianna Laviola; Nadir Yehya; John G Laffey; Jonathan G Hardman; Declan G Bates
Journal:  Crit Care Explor       Date:  2020-09-18

2.  Pathophysiology of COVID-19-associated acute respiratory distress syndrome.

Authors:  Vasiliki Tsolaki; George E Zakynthinos; Konstantinos Mantzarlis; Vasileios Vazgiourakis; Dimosthenis Makris
Journal:  Lancet Respir Med       Date:  2020-11-13       Impact factor: 30.700

Review 3.  [Treatment recommendations for mechanical ventilation of COVID‑19 patients].

Authors:  B Neetz; F J F Herth; M M Müller
Journal:  Gefasschirurgie       Date:  2020-09-18

4.  Rapid and Impressive Response to a Combined Treatment with Single-Dose Tocilizumab and NIV in a Patient with COVID-19 Pneumonia/ARDS.

Authors:  Marco Cascella; Immacolata Mauro; Elvio De Blasio; Anna Crispo; Alfredo Del Gaudio; Sabrina Bimonte; Arturo Cuomo; Paolo Antonio Ascierto
Journal:  Medicina (Kaunas)       Date:  2020-07-27       Impact factor: 2.430

5.  Identification of a Circulating miRNA Signature to Stratify Acute Respiratory Distress Syndrome Patients.

Authors:  Gennaro Martucci; Antonio Arcadipane; Fabio Tuzzolino; Giovanna Occhipinti; Giovanna Panarello; Claudia Carcione; Eleonora Bonicolini; Chiara Vitiello; Roberto Lorusso; Pier Giulio Conaldi; Vitale Miceli
Journal:  J Pers Med       Date:  2020-12-27

6.  A Potential Role of the Renin-Angiotensin-System for Disturbances of Respiratory Chemosensitivity in Acute Respiratory Distress Syndrome and Severe Acute Respiratory Syndrome.

Authors:  Swen Hülsmann; Sepideh Khabbazzadeh; Konrad Meissner; Michael Quintel
Journal:  Front Physiol       Date:  2021-01-20       Impact factor: 4.566

Review 7.  Implications of microscale lung damage for COVID-19 pulmonary ventilation dynamics: A narrative review.

Authors:  Elizabeth Dimbath; Veeranna Maddipati; Jennifer Stahl; Kerry Sewell; Zachary Domire; Stephanie George; Ali Vahdati
Journal:  Life Sci       Date:  2021-03-11       Impact factor: 6.780

Review 8.  Functional pathophysiology of SARS-CoV-2-induced acute lung injury and clinical implications.

Authors:  Nader M Habashi; Luigi Camporota; Louis A Gatto; Gary Nieman
Journal:  J Appl Physiol (1985)       Date:  2021-01-14

Review 9.  Heart-lung interactions in COVID-19: prognostic impact and usefulness of bedside echocardiography for monitoring of the right ventricle involvement.

Authors:  Michael Dandel
Journal:  Heart Fail Rev       Date:  2021-04-17       Impact factor: 4.654

10.  Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.

Authors: 
Journal:  Intensive Care Med       Date:  2020-10-29       Impact factor: 41.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.